Advances in HCV Therapy

989 as a NA a of of 992 of of DN 1990in of CV , 2002 4 M 0 M 32 M 0M 0 M 999 9 M 0 M 170 3 - 4 MM 3% A 00,000 6 3 4 5 2 , 1999 NA be in -3 to -9 to -7 in 0% of 0% in 0% 1998; 47(1 H 1997;26 (): 15, 2002 *S. . at , 2000 of 1st 2nd 983 1985 1987 1989 1991 1993 CV % 250,00000 5 5 of 2001) 100,00000 2nd 8000 2000 . et 2001; 2753. 3. ; 2003 05 01 10002000300040005000600070008000#991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004Y e a n o t if ic a t io n s b y y e a r 10000200003000040000500006000070000800001990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004C u m u l a ti v en o ti fi c a ti o n 5101520253035%1 5 1 5 2 0 3 0 4 0 5 0 6 0Y e a r sA g e d is t r ib u t io n o f p o s it iv e a n t C V r e s u lt - 198800,000 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 , A of in 1,00000 to in 0 0 an of 1998; 47(1 , 2002 100,00000 Ex/ of ? ? ? . 3 1 . 32 0 . 13 . 77 . 631 . 182 . 73 0 . 12 0 . 205101520253035%sp) an t i - H C V - p o si t i b y r i f ac t o r ( l as t 5 y ea r s) ( of of or 992 of of or in of to or an or to J. J 1998;10:12 s H O R e g i o n T o t a l P o p u l a t i o n( M i l l i o n s )H e p a t i t i s Cp r e v a l e n c eR a t e %I n f e c t e dP o p u l a t i o n( M i l l i o n s )A f r i c a 602 5 . 3 3 1 . 9A m e r i c a s 785 1 . 7 1 3 . 1E a s t e r nM e d i t e r r a n e a . 6 2 1 . 3E u r o p e 858 1 . 0 3 8 . 9S o u t h - E a s t A s i a 1 5 0 0 2 . 1 5 3 2 . 3W e s t e r n P a c i f i c 1 6 0 0 3 . 9 6 2 . 2T o t a l 5 8 1 1 3 . 1 1 6 9 . 7 In of O U N T R Y R A T E ( % ) C O U N T R Y R A T E ( % )I T A L Y 0 . 5 I N D I A 1 . 8G R E E C E 1 . 5 P A K I S T A N 2 . 4E G Y P T 1 8 . 1 P H I L L I P I N E S 3 . 6S O M A L I A 0 . 9 R W A N D A 1 7 . 0H O N G K O N G 0 . 5 V I E T N A M 6 . 1R O M A N I A 4 . 5 R U S S I A 2 . 0K O R E A 1 . 7 P O L A N D 1 . 4. 1999;285:26. N F 488 N 0S N 60S F et 000 N N et 000 et 000 et 998 N N - 74% - 49% F F T F F 0 90 % ( 20“ N 70F F H. 1997;26():16S. 5%70% 5% % F F O BV et 1998 F 61231401858648502040608010010 20 30 40Y S A F T U R E% V+A L in 28%279%223%68%61%0% 100% 200% 300% 400% 500% 600%E s t i m a t e d % i n c re a s e b y y e a r 2 0 0 8C i rr h o s i i v e r- re l a t e d d e a t h sD e c o m p e n s a t i o nN e e d f o r l i v e rt ra n s p l a n t a t i o et 1998 010S 193,000 720,700 of of $11 in $21.3 54 0 m J 000 J 1999 re he we be in a of be if . 1997. of 9% of 2 in of of . 2002. of in on of . 2002. be T or of of of of of is to VR %) No 989 1999 2002 4 8 6% 0%